SUPERSTRING CAPITAL MANAGEMENT LP
NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$199.5M2026 Q3
Positions35
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.59.5%
What Changed This Quarter?
Top Holdings
COGT
Cogent Biosciences
9.6%
AXSM
Axsome Therapeutics
9.5%
TRVI
Trevi Therapeutics
7.1%
GMAB
Genmab A/S
6.5%
CLYM
Climb Bio
5.3%
ZLAB
Zai Lab
4.8%
ANL
Adlai Nortye
4.7%
RVMD
Revolution Medicines
4.3%
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.